Jane Huang - Jun 9, 2021 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Director
Signature
/s/ Karen Deschaine, Attorney-in-Fact
Stock symbol
TARA
Transactions as of
Jun 9, 2021
Transactions value $
$0
Form type
4
Date filed
6/10/2021, 09:35 PM
Previous filing
Jun 9, 2021
Next filing
Jun 21, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARA Stock Option (Right to Buy) Award $0 +20K $0.00 20K Jun 9, 2021 Common Stock 20K $10.51 Direct F1
transaction TARA Stock Option (Right to Buy) Award $0 +10K $0.00 10K Jun 9, 2021 Common Stock 10K $10.51 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in a series of 36 successive equal monthly installments over the three-year period measured from the date of grant, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.
F2 The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.